BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/28/2024 3:06:31 AM | Browse: 148 | Download: 617
 |
Received |
|
2024-06-26 09:37 |
 |
Peer-Review Started |
|
2024-06-25 05:08 |
 |
First Decision by Editorial Office Director |
|
2024-11-18 10:06 |
 |
Return for Revision |
|
2024-11-18 10:06 |
 |
Revised |
|
2024-11-18 16:51 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2024-11-26 02:41 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-11-26 08:04 |
 |
Articles in Press |
|
2024-11-26 08:04 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-11-27 00:25 |
 |
Publish the Manuscript Online |
|
2024-11-28 03:06 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Virology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Revisiting dexamethasone dosage in COVID-19 management
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abhishet Varama |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abhishet Varama, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Rd, Pathum Wan, Bangkok 10330, Krung Thep Maha Nakhon, Thailand. abhishet.varama@docchula.com |
| Key Words |
COVID-19 treatment; Dexamethasone dosage; Personalized medicine; Letter; Clinical adaptability |
| Core Tip |
This editorial delves into the critical analysis provided by Sethi et al on dexamethasone dosing in severe coronavirus disease 2019 (COVID-19) cases. Highlighting the review's challenge to the one-size-fits-all approach, it emphasizes the need for personalized medicine and calls for further research to refine treatment protocols based on emerging evidence and patient-specific factors. The editorial advocates for the integration of nuanced clinical data to enhance therapeutic strategies against COVID-19, fostering a broader discussion on the adaptability of clinical practice in pandemic responses and the potential for tailored patient care. |
| Publish Date |
2024-11-28 03:06 |
| Citation |
Varama A. Revisiting dexamethasone dosage in COVID-19 management. World J Virol 2025; 14(1): 98359 |
| URL |
https://www.wjgnet.com/2220-3249/full/v14/i1/98359.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v14.i1.98359 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.